Nucleotide Market By By Technology (Gene chips & microarrays, SNP by pyrosequencing), Application (Pharmaceuticals, Diagnostics research, Food & beverage additive)& Region - Forecast to 2021 - 2031
Market Insights on Nucleotide covering sales outlook, demand forecast and up-to-date key trends
[350 Pages Report] Newly released data from nucleotides market analysis shows that global demand of overall nucleotides market enjoyed year-on-year growth of 5.8% in 2021 to total US$ 559.9 Mn and it is expected to grow with a CAGR of 6.1% over the forecasted period.
In the past few years, the consumer base around the globe is becoming aware of the usage of premixes in infant nutrition applications. Thus consumers started opting for infant nutrition products containing premixes which are expected to trigger growth to the nucleotides market.
In addition to this, the disposable income of the consumer base around the globe is increasing and, as a result, their propensity to spend on food products with improved health benefits is also increasing. Thus the consumer base around the globe started opting for food products with health beneficial ingredients such as nucleotides.
Sales of nucleotides will represent 5.8% of the overall demand in the global customized premix market. The increasing demand for food premixes owing to health benefits associated with it is propelling growth to the overall customized premix market. Moreover, growing awareness among the pet owners regarding the diet of their pet is increasing demand for feed premixes which is expected to propel growth to the nucleotides market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Market Statistics
Details
H1,2021 (A)
5.7%
H1,2022 Projected (P)
5.8%
H1,2022 Outlook (O)
6.4%
BPS Change : H1,2022 (O) - H1,2022 (P)
(+) 58 ↑
BPS Change : H1,2022 (O) - H1,2021 (A)
(+) 63.8 ↑
FMI provides a half-yearly comparison study and evaluation of the worldwide market's growth rates as well as its future development potential. Under the subjective effect of macro and industry variables, certain demographic and innovation aspects dominate the market.
Some new developments that have taken place in these markets include:
Thermo Fisher Scientific successfully acquired PPD Inc. in December 2021. Nucleotides are among the things that the business offers.
In terms of dietary requirements and physiological processes, nucleotides are essential. In order to improve food's palatability, inosine monophosphate (IMP) and guanosine monophosphate (GMP) are frequently utilized. This aids in improving the taste of nucleotides for feed.
Additionally, nucleotides have an impact on the immunity-boosting recovery of intestinal epithelial cells. Immune tissue cells are unable to produce nucleotides on their own. Thus, dietary nucleotides help to boost immunity.
Maintaining sufficient metabolism rates in cattle is necessary due to the increasing prevalence of animal illnesses. In this market, consumer awareness has also developed, which has raised the need for animal feed.
The International Feed Industry Federation estimates that the yearly global output of compound feed has surpassed 1 billion tonnes. Over $400 billion in revenue is reportedly generated annually by the production of commercial feeds worldwide. ?
The global market for nucleotides is expected to rise by 5.7 percent in the first half of 2021. But not all regions have experienced this increase equally, with developing markets experiencing greater growth rates of 6.4 percent (H1 2022 Expected). The difference between predicted and projected growth for H1 2022 is hence 63.8 BPS points.
The primary causes of this variation in growth rate are ascribed to the market's slow or rapid uptake during the first half of the projected period as a result of improving end user demand in important economies and their expanding populations. Particularly, the consumption patterns of the USA and China are both increasing, which is driving up demand for nucleotides.
5.8% of the total global demand for customised premix will be met by sales of nucleotides. The market for customised premixes as a whole is expanding due to the rising demand for food premixes and their associated health benefits. Additionally, the demand for feed premixes is rising as pet owners become more aware of what their pets should eat, which is anticipated to drive expansion in the nucleotides market.
In the second half of the projection period, numerous other market segments are anticipated to perform reasonably and achieve attractive development possibilities.
Despite these promising developments, the business is still expected to face significant obstacles, such as shifting customer tastes, strict trade restrictions, and a lack of security in the supply of raw materials and other production inputs.
2016-2020 Nucleotides Market Outlook in Comparison to 2021-2031 Growth Forecast
The global nucleotides market is expected to value at US$ 559.9 Mn in 2021. However, it is projected to reach US$ 1,010.5 Mn by the end of 2031 growing with a CAGR of 6.1%.
The global nucleotide market is now seeing rapid expansion. To a certain extent, growth is due to increased demand from a variety of end consumers. Nucleotides, for example, have seen a significant surge in use in animal feed additives, the food and beverage sector, pharmaceuticals, and research and diagnostics. The market is expected to see a significant increase in demand in the coming years. As customers become more aware of the adverse consequences of savoury additives, sales of nucleotide-based flavour enhancers are expected to rise in the coming years.
Furthermore, the market's growth prospects will be boosted by the expanding spectrum of use in the pharmaceuticals sector, particularly in Canada and the United States, as well as continually rising demand from the cattle industry.
Country-wise Analysis
The Presence of Key Players in the Nucleotides Market is Souring Growth to the US Nucleotides Market
According to FMI, the US is dominating the North American region with a market share of 91.2% valued at US$ 175.6 Mn in the year 2021 and it is expected to reach US$ 286.7 Mn by the year 2031 growing at a CAGR of 5.6% over the forecasted period.
The presence of key players in the US is one of the major growth enablers to the US nucleotides market. These key players are focusing on changing consumer demand and hence introducing the products according to the need of the consumers. For instance, some manufacturers have introduced gluten-free nucleotide premix to the market. As the huge consumer base in the US are demanding gluten-free food products the demand for gluten-free ingredients such as nucleotides which are used in food products is also gaining traction.
Growing Concern Regarding Infant Nutrition Promoting Sales of Nucleotides in Germany
The German nucleotides market size in 2021 is estimated to account for a value of US$ 33.6 Mn and it is expected to grow with a CAGR of 5.5% over the forecasted period reaching US$ 54.2 Mn.
The key reason behind the dominance of Germany in the European nucleotides market is the growing demand for nucleotides in infant nutrition. From the past few years, the consumer base in Germany has become aware of the positive impact of nucleotides enriched baby food on infant nutrition. Thus the demand for nucleotides enriched baby food is souring growth to the German nucleotides market.
Increasing Incidences of Animal Diseases Promoting Sales of Nucleotides in the UK
Animals' nucleotides are digested in the gut, which has an impact on the proliferation of beneficial gut bacteria. ATP breakdown begins immediately after an animal dies due to respiratory arrest, resulting in the synthesis of catabolite nucleotides such as inosine (Ino), inosine monophosphate (IMP), and, later, hypoxanthine (Hx). Measuring nucleotide levels in tissues provides an objective indicator of the freshness of fish and meat, such as beef, pork, lamb, poultry, and sub-products.
Thus due to increasing incidents of animal diseases, the consumer base in the UK have become aware of maintaining adequate metabolism rates in livestock which is propelling growth to the UK nucleotides market.
Growing Demand for Food Products with High Nutritional Value is a Key Growth Enabler for the Nucleotides Market in India
India is dominating the South Asia nucleotides market holding a 40.6% share valued at US$ 2,242.2 Mn in the year 2021 and it is expected to grow with a CAGR of 9.7% reaching a market value of US$ 5,142.4 Mn by the year 2031.
Being one of the prominent developing countries the disposable income of the consumer base in India is continuously increasing. Thus with increasing disposable income consumers’ willingness to spend on nutritional food products is also increasing. Thus food product manufacturers are using ingredients such as nucleotides which help in increasing the nutritional value of the product. Hence the growing demand for nutritional food products is promoting sales of nucleotides in India.
Growing Demand for Flavour Enhancers is Triggering Growth to the Nucleotides Market in China
For the past few years, China is experiencing significant growth in the demand for flavour enhancers. As the nucleotides boost sensory acceptability through taste and flavour, increase the richness, impact, continuity, and harmony of food flavours. Moreover, it also enhances the performance of smells, and provide for cost savings in formulations. Owing to which the sales of nucleotides are expected to gain traction in China and it is expected to grow with a significant CAGR of 8.9% over the forecasted period.
Category-wise Insights
Diagnostic Research Dominating Application Segment of Nucleotides Market
According to FMI, the Diagnostic research segment is holding a market share of 62.0% valued at US$ 346.9 Mn in the year 2021 and it is expected to reach US$ 617.5 Mn by 2031 growing at a CAGR of 6.6%. From the past few years, the demand for quick and accurate diagnosis of numerous genetic diseases is increasing.
Thus with the growing demand for quick and accurate diagnosis, the demand for nucleotides is also increasing as it is one of the best alternatives available in the market for diagnostic research.
TaqMan Allelic Discrimination Technology is one of the Prominent Technology in the Nucleotides Market
According to FMI, TaqMan Allelic Discrimination technology is estimated to dominate the technology segment holding a 45.8% share in the global market valued at US$ 256.6 Mn in the year 2021 and it is expected to grow with 6.8% CAGR in the forecasted period.
TaqMan allelic discrimination, which has been widely used to define single nucleotide polymorphisms, is one of the most effective approaches to evaluate genotypes.
However, there are numerous disorders caused by massive deletions that can only be detected by copy number analysis, multiplex ligation-dependent probe amplification, or direct sequencing, all of which are time-consuming, expensive, and difficult to interpret and utilize in high-throughput research. Thus as an alternative approach, TaqMan allelic discrimination technology is used.
Find your sweet spots for generating winning opportunities in this market.
Competition Landscape: Top Nucleotides Companies
According to market research analysis Ohly GmbHNanjing Bio Together Co., Ltd., ThermoFisher Scientific Inc., Agilent Technologies Inc., DSM Nutritional Products Ltd., Lallemand Inc., Affymetrix Inc., PR omega Corporation, Biorigin, Meihua Group, Star Lake Bioscience Co., NuEra Nutrition, F. Hoffmann-La Roche Ltd., CJ CheilJedang Corporation and many other.
Companies today operate in a fast-paced business climate, guided by shifting consumer desires. To be relevant in the market, it is critical that they keep track of changing consumer tastes and preferences. Companies are focusing on the launch of products with unique qualities, driven by the increased demand for nutritional premixes.
Scope of Report
Attribute
Details
Market Size Value in 2020
US$ 529.2 Million
Market Forecast Value in 2031
US$ 1,010.5 Million
Global Growth Rate
6.1
Forecast Period
2021 to 2031
Historical Data Available for
2016 to 2020
Market Analysis
MT for Volume and US$ Mn for Value
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA
Key Countries Covered
United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Personalize your report by choosing insights you need and save 40%!
Market Segments Covered in Nucleotides Industry Analysis
By Technology:
TaqMan allelic discrimination
SNP by pyrosequencing
Gene chips & microarrays
Others
By Application:
Food & beverage additive
Animal feed additive
Pharmaceuticals
Diagnostics research
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA
Frequently Asked Questions
How much is the Nucleotides market current worth?
Currently nucleotides market is worth more than US$ 529.2 Mn.
At what CAGR is the market expected to grow?
Nucleotides consumption is expected to grow at a CAGR of around 6.1% during the period 2021-2031.
How was the performance in the last five years?
In terms of revenue, nucleotides grew at a CAGR of around 4.9% during 2016-2020
What are the key trends boosting Nucleotides sales?
Rising demand for better nutritive qualities in flavour enhancers is the latest trend of nucleotides being observed in the market.
How are market players reacting to the new developments in the market?
Market players are opting for technological advancement, new product developments and production capacity expansion.
How much share does the top 5 companies hold?
The top 5 producers of nucleotides hold around 20-30% of the market share.
Which are the major countries driving demand for nucleotides?
The US, China Germany, and China are the major countries driving demand for nucleotides.
What outlook does East Asia provide?
East Asia holds around 12.8% of the total nucleotides revenue share.
At what rate will the U.S. nucleotides market grow?
US nucleotides market is projected to grow at a CAGR of around 5.6% over the next ten years.
At what level does the report reflect pricing analysis?
The report presents a detailed cost analysis of nucleotides based on nature i.e. organic and conventional.
What is nucleotide?
A nucleotide is an organic molecule that is the building block of DNA and RNA.
What is the use of nucleotide?
Nucleotides are in particular essential for replication of DNA and transcription of RNA in rapidly dividing stages.
Table of Content
1. Market Overview
1.1. Market Coverage / Taxonomy
1.2. Market Definition / Scope / Limitations
2. The Massive Impact of the Crisis
2.1. Global Market Forecast Scenario Comparison of Annual Growth Rates for short Term (2021-2025) and Long Term (2026-2031)
2.1.1. Optimistic Scenario
2.1.2. Likely Scenario
2.1.3. Pessimistic Scenario
2.2. Key Factors Impacting the Market
Note: Market Assessment shall be Provided for Likely Scenario
3. Market Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends By Region
3.5. Product Launches
3.6. Product Claims & Nutritional Information Scan by Buyers
3.7. Macro-Economic Factors
3.8. Forecast Factors - Relevance & Impact
3.9. Consumers Survey Analysis
4. Key Regulations
4.1. Packaging & Labelling Regulations
4.2. Certifications and Certifying Agency Overview
4.3. Import/Export Policies
5. Value Chain Analysis
5.1. Operating margins at each node of supply chain
5.2. List of Active Market Participants
5.2.1. Raw Material Suppliers
5.2.2. Product Manufacturers
5.2.3. Key Brands
6. Global Market Demand Analysis 2016-2020 and Forecast, 2021-2031
6.1. Historical Market Volume (Metric Tons) Analysis, 2016-2020
6.2. Current and Future Market Volume (Metric Tons) Projections, 2021-2031
6.3. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis (US$/Metric Tons) By Prominent Regions
7.2. Pricing Break-up By category
7.3. Global Average Pricing Analysis Benchmark
8. Global Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
8.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Technology
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Technology, 2016 - 2020
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Technology, 2021-2031
9.3.1. TaqMan allelic discrimination
9.3.2. Gene chips & microarrays
9.3.3. SNP by pyrosequencing
9.3.4. Others
9.4. Market Attractiveness Analysis By Technology
10. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2016 - 2020
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2021-2031
10.3.1. Pharmaceuticals
10.3.2. Diagnostics research
10.3.3. Food & beverage additive
10.3.4. Animal feed additive
10.3.5. Others
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2016 - 2020
11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021-2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.2. By Technology
12.4.3. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Technology
12.5.2. By Application
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Latin America Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
13.4.1. By Country
13.4.2. Brazil
13.4.3. Mexico
13.4.4. Rest of Latin America
13.4.5. By Technology
13.4.6. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Technology
13.5.2. By Application
13.6. Market Attractiveness Analysis
13.7. Market Trends
13.8. Key Market Participants - Intensity Mapping
13.9. Drivers and Restraints - Impact Analysis
14. Europe Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
14.4.1. By Country
14.4.2. Germany
14.4.3. Italy
14.4.4. France
14.4.5. U.K.
14.4.6. Spain
14.4.7. BENELUX
14.4.8. Russia
14.4.9. Rest of Europe
14.4.10. By Technology
14.4.11. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Technology
14.5.2. By Application
14.6. Market Attractiveness Analysis
14.7. Market Trends
14.8. Key Market Participants - Intensity Mapping
14.9. Drivers and Restraints - Impact Analysis
15. East Asia Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
15.4.1. By Country
15.4.2. China
15.4.3. Japan
15.4.4. South Korea
15.4.5. By Technology
15.4.6. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Technology
15.5.2. By Application
15.6. Market Attractiveness Analysis
15.7. Market Trends
15.8. Key Market Participants - Intensity Mapping
15.9. Drivers and Restraints - Impact Analysis
16. South Asia Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
16.4.1. By Country
16.4.2. India
16.4.3. Thailand
16.4.4. Indonesia
16.4.5. Malaysia
16.4.6. Singapore
16.4.7. Rest of South Asia
16.4.8. By Technology
16.4.9. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Technology
16.5.2. By Application
16.6. Market Attractiveness Analysis
16.7. Market Trends
16.8. Key Market Participants - Intensity Mapping
16.9. Drivers and Restraints - Impact Analysis
17. Oceania Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
17.4.1. By Country
17.4.2. Australia
17.4.3. New Zealand
17.4.4. By Technology
17.4.5. By Application
17.5. Market Attractiveness Analysis
17.5.1. By Technology
17.5.2. By Application
17.6. Market Attractiveness Analysis
17.7. Market Trends
17.8. Key Market Participants - Intensity Mapping
17.9. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
18.4.1. By Country
18.4.1.1. GCC Countries
18.4.1.2. North Africa
18.4.1.3. South Africa
18.4.1.4. Rest of Middle East and Africa
18.4.2. By Technology
18.4.3. By Application
18.5. Market Attractiveness Analysis
18.5.1. By Technology
18.5.2. By Application
18.6. Market Attractiveness Analysis
18.7. Market Trends
18.8. Key Market Participants - Intensity Mapping
18.9. Drivers and Restraints - Impact Analysis
19. Key Countries Nucleotides Market Analysis 2016–2020 and Forecast 2021–2031
19.1. U.S.
19.1.1. Introduction
19.1.2. Pricing Analysis (2016, 2021, 2031)
19.1.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.1.3.1. By Technology
19.1.3.2. By Application
19.2. Canada
19.2.1. Pricing Analysis (2016, 2021, 2031)
19.2.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.2.2.1. By Technology
19.2.2.2. By Application
19.3. Brazil
19.3.1. Pricing Analysis (2016, 2021, 2031)
19.3.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.3.2.1. By Technology
19.3.2.2. By Application
19.4. Mexico
19.4.1. Pricing Analysis (2016, 2021, 2031)
19.4.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.4.2.1. By Technology
19.4.2.2. By Application
19.5. Argentina
19.5.1. Pricing Analysis (2016, 2021, 2031)
19.5.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.5.2.1. By Technology
19.5.2.2. By Application
19.6. Chile
19.6.1. Pricing Analysis (2016, 2021, 2031)
19.6.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.6.2.1. By Technology
19.6.2.2. By Application
19.7. Germany
19.7.1. Pricing Analysis (2016, 2021, 2031)
19.7.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.7.2.1. By Technology
19.7.2.2. By Application
19.8. Italy
19.8.1. Pricing Analysis (2016, 2021, 2031)
19.8.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.8.2.1. By Technology
19.8.2.2. By Application
19.9. France
19.9.1. Pricing Analysis (2016, 2021, 2031)
19.9.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.9.2.1. By Technology
19.9.2.2. By Application
19.10. U.K.
19.10.1. Pricing Analysis (2016, 2021, 2031)
19.10.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.10.2.1. By Technology
19.10.2.2. By Application
19.11. Spain
19.11.1. Pricing Analysis (2016, 2021, 2031)
19.11.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.11.2.1. By Technology
19.11.2.2. By Application
19.12. Benelux
19.12.1. Pricing Analysis (2016, 2021, 2031)
19.12.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.12.2.1. By Technology
19.12.2.2. By Application
19.13. Russia
19.13.1. Pricing Analysis (2016, 2021, 2031)
19.13.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.13.2.1. By Technology
19.13.2.2. By Application
19.14. India
19.14.1. Pricing Analysis (2016, 2021, 2031)
19.14.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.14.2.1. By Technology
19.14.2.2. By Application
19.15. Thailand
19.15.1. Pricing Analysis (2016, 2021, 2031)
19.15.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.15.2.1. By Technology
19.15.2.2. By Application
19.16. Indonesia
19.16.1. Pricing Analysis (2016, 2021, 2031)
19.16.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.16.2.1. By Technology
19.16.2.2. By Application
19.17. Malaysia
19.17.1. Pricing Analysis (2016, 2021, 2031)
19.17.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.17.2.1. By Technology
19.17.2.2. By Application
19.18. China
19.18.1. Pricing Analysis (2016, 2021, 2031)
19.18.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.18.2.1. By Technology
19.18.2.2. By Application
19.19. Japan
19.19.1. Pricing Analysis (2016, 2021, 2031)
19.19.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.19.2.1. By Technology
19.19.2.2. By Application
19.20. South Korea
19.20.1. Pricing Analysis (2016, 2021, 2031)
19.20.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.20.2.1. By Technology
19.20.2.2. By Application
19.21. Australia
19.21.1. Pricing Analysis (2016, 2021, 2031)
19.21.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.21.2.1. By Technology
19.21.2.2. By Application
19.22. New Zealand
19.22.1. Pricing Analysis (2016, 2021, 2031)
19.22.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.22.2.1. By Technology
19.22.2.2. By Application
19.23. GCC Countries
19.23.1. Pricing Analysis (2016, 2021, 2031)
19.23.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.23.2.1. By Technology
19.23.2.2. By Application
19.24. Central Africa
19.24.1. Pricing Analysis (2016, 2021, 2031)
19.24.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.24.2.1. By Technology
19.24.2.2. By Application
19.25. Northern Africa
19.25.1. Pricing Analysis (2016, 2021, 2031)
19.25.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.25.2.1. By Technology
19.25.2.2. By Application
19.26. South Africa
19.26.1. Pricing Analysis (2016, 2021, 2031)
19.26.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
19.26.2.1. By Technology
19.26.2.2. By Application
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Company Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive (Tentative List)
21.2.1. Ohly GmbH
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
21.2.1.4. Sales Footprint
21.2.1.5. Strategy Overview
21.2.1.5.1. Marketing Strategy
21.2.1.5.2. Product Strategy
21.2.2. Nanjing Bio Together Co., Ltd.
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
21.2.2.4. Sales Footprint
21.2.2.5. Strategy Overview
21.2.2.5.1. Marketing Strategy
21.2.2.5.2. Product Strategy
21.2.3. Agilent Technologies Inc.
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
21.2.3.4. Sales Footprint
21.2.3.5. Strategy Overview
21.2.3.5.1. Marketing Strategy
21.2.3.5.2. Product Strategy
21.2.4. PR omega Corporation
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
21.2.4.4. Sales Footprint
21.2.4.5. Strategy Overview
21.2.4.5.1. Marketing Strategy
21.2.4.5.2. Product Strategy
21.2.5. Biorigin
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
21.2.5.4. Sales Footprint
21.2.5.5. Strategy Overview
21.2.5.5.1. Marketing Strategy
21.2.5.5.2. Product Strategy
21.2.6. Meihua Group
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
21.2.6.4. Sales Footprint
21.2.6.5. Strategy Overview
21.2.6.5.1. Marketing Strategy
21.2.6.5.2. Product Strategy
21.2.7. Star Lake Bioscience Co.
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
21.2.7.4. Sales Footprint
21.2.7.5. Strategy Overview
21.2.7.5.1. Marketing Strategy
21.2.7.5.2. Product Strategy
21.2.8. NuEra Nutrition
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
21.2.8.4. Sales Footprint
21.2.8.5. Strategy Overview
21.2.8.5.1. Marketing Strategy
21.2.8.5.2. Product Strategy
21.2.9. Lallemand Inc.
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
21.2.9.4. Sales Footprint
21.2.9.5. Strategy Overview
21.2.9.5.1. Marketing Strategy
21.2.9.5.2. Product Strategy
21.2.10. Affymetrix Inc.
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Profitability by Market Segments (Product/Channel/Region)
21.2.10.4. Sales Footprint
21.2.10.5. Strategy Overview
21.2.10.5.1. Marketing Strategy
21.2.10.5.2. Product Strategy
21.2.11. DSM Nutritional Products Ltd.
21.2.11.1. Overview
21.2.11.2. Product Portfolio
21.2.11.3. Profitability by Market Segments (Product/Channel/Region)
21.2.11.4. Sales Footprint
21.2.11.5. Strategy Overview
21.2.11.5.1. Marketing Strategy
21.2.11.5.2. Product Strategy
21.2.12. F. Hoffmann-La Roche Ltd.
21.2.12.1. Overview
21.2.12.2. Product Portfolio
21.2.12.3. Profitability by Market Segments (Product/Channel/Region)
21.2.12.4. Sales Footprint
21.2.12.5. Strategy Overview
21.2.12.5.1. Marketing Strategy
21.2.12.5.2. Product Strategy
21.2.13. ThermoFisher Scientific Inc.
21.2.13.1. Overview
21.2.13.2. Product Portfolio
21.2.13.3. Profitability by Market Segments (Product/Channel/Region)
21.2.13.4. Sales Footprint
21.2.13.5. Strategy Overview
21.2.13.5.1. Marketing Strategy
21.2.13.5.2. Product Strategy
21.2.14. CJ CheilJedang Corporation
21.2.14.1. Overview
21.2.14.2. Product Portfolio
21.2.14.3. Profitability by Market Segments (Product/Channel/Region)
21.2.14.4. Sales Footprint
21.2.14.5. Strategy Overview
21.2.14.5.1. Marketing Strategy
21.2.14.5.2. Product Strategy
21.2.15. Others Prominent Players
21.2.15.1. Overview
21.2.15.2. Product Portfolio
21.2.15.3. Profitability by Market Segments (Product/Channel/Region)
21.2.15.4. Sales Footprint
21.2.15.5. Strategy Overview
21.2.15.5.1. Marketing Strategy
21.2.15.5.2. Product Strategy
22. Assumptions and Acronyms Used23. Research Methodolog
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Nucleotides Market Value (US$ Mn) and Forecast by Region, 2016–2020
Table 2: Global Nucleotides Market Value (US$ Mn) and Forecast by Region, 2021–2031
Table 3: Global Nucleotides Market Volume (Metric Tons) and Forecast by Region, 2016–2020
Table 4: Global Nucleotides Market Volume (Metric Tons) and Forecast by Region, 2021–2031
Table 5: Global Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020
Table 6: Global Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031
Table 7: Global Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020
Table 8: Global Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031
Table 9: Global Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020
Table 10: Global Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031
Table 11: Global Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020
Table 12: Global Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Table 13: North America Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020
Table 14: North America Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031
Table 15: North America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020
Table 16: North America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031
Table 17: North America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020
Table 18: North America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031
Table 19: North America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020
Table 20: North America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031
Table 21: North America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020
Table 22: North America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031
Table 23: North America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020
Table 24: North America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Table 25: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020
Table 26: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031
Table 27: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020
Table 28: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031
Table 29: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020
Table 30: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031
Table 31: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020
Table 32: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031
Table 33: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020
Table 34: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031
Table 35: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020
Table 36: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Table 37: Europe Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020
Table 38: Europe Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031
Table 39: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020
Table 40: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031
Table 41: Europe Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020
Table 42: Europe Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031
Table 43: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020
Table 44: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031
Table 45: Europe Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020
Table 46: Europe Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031
Table 47: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020
Table 48: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Table 49: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020
Table 50: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031
Table 51: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020
Table 52: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031
Table 53: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020
Table 54: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031
Table 55: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020
Table 56: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031
Table 57: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020
Table 58: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031
Table 59: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020
Table 60: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Table 61: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020
Table 62: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031
Table 63: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020
Table 64: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031
Table 65: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020
Table 66: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031
Table 67: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020
Table 68: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031
Table 69: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020
Table 70: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031
Table 71: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020
Table 72: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Table 73: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020
Table 74: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031
Table 75: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020
Table 76: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031
Table 77: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020
Table 78: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031
Table 79: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020
Table 80: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031
Table 81: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020
Table 82: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031
Table 83: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020
Table 84: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Table 85: MEA Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020
Table 86: MEA Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031
Table 87: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020
Table 88: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031
Table 89: MEA Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020
Table 90: MEA Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031
Table 91: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020
Table 92: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031
Table 93: MEA Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020
Table 94: MEA Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031
Table 95: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020
Table 96: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Nucleotides Market Value (US$ Mn) and Volume (MT) Forecast, 2021–2031
Figure 02: Global Nucleotides Market Absolute $ Opportunity (US$ Mn), 2021?2031
Figure 03: Global Nucleotides Market Value (US$ Mn) and % Growth by Region, 2021 & 2031
Figure 04: Global Nucleotides Market Y-o-Y Growth Rate by Region, 2021 - 2031
Figure 05: Global Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031
Figure 06: Global Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031
Figure 07: Global Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031
Figure 8: Global Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031
Figure 9: Global Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031
Figure 10: Global Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031
Figure 11: North America Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031
Figure 12: North America Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031
Figure 13: North America Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031
Figure 14: North America Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031
Figure 15: North America Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031
Figure 16: North America Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031
Figure 17: North America Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031
Figure 18: North America Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031
Figure 19: North America Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031
Figure 20: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031
Figure 21: Latin America Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031
Figure 22: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031
Figure 23: Latin America Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031
Figure 24: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031
Figure 25: Latin America Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031
Figure 26: Latin America Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031
Figure 27: Latin America Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031
Figure 28: Latin America Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031
Figure 29: Europe Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031
Figure 30: Europe Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031
Figure 31: Europe Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031
Figure 32: Europe Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031
Figure 33: Europe Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031
Figure 34: Europe Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031
Figure 35: Europe Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031
Figure 36: Europe Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031
Figure 37: Europe Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031
Figure 38: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031
Figure 39: East Asia Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031
Figure 40: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031
Figure 41: East Asia Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031
Figure 42: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031
Figure 43: East Asia Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031
Figure 44: East Asia Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031
Figure 45: East Asia Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031
Figure 46: East Asia Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031
Figure 47: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031
Figure 48: South Asia Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031
Figure 49: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031
Figure 50: South Asia Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031
Figure 51: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031
Figure 52: South Asia Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031
Figure 53: South Asia Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031
Figure 54: South Asia Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031
Figure 55: South Asia Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031
Figure 56: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031
Figure 57: Oceania Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031
Figure 58: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031
Figure 59: Oceania Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031
Figure 60: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031
Figure 61: Oceania Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031
Figure 62: Oceania Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031
Figure 63: Oceania Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031
Figure 64: Oceania Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031
Figure 65: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031
Figure 66: Middle East & Africa Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031
Figure 67: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031
Figure 68: Middle East & Africa Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031
Figure 69: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031
Figure 70: Middle East & Africa Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031
Figure 71: Middle East & Africa Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031
Figure 72: Middle East & Africa Nucleotides Market Attractiveness Analysis by Application, 2021 – 2031
